N-((S)-1-((R)-1-(1,3,6,2-dioxazaborocan-2-yl)-3-methylbutylamino)-3-methoxy-1-oxopropan-2-yl)-2,5-dichlorobenzamide

ID: ALA4248209

PubChem CID: 145984824

Max Phase: Preclinical

Molecular Formula: C20H30BCl2N3O5

Molecular Weight: 474.19

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC[C@H](NC(=O)c1cc(Cl)ccc1Cl)C(=O)N[C@@H](CC(C)C)B1OCCNCCO1

Standard InChI:  InChI=1S/C20H30BCl2N3O5/c1-13(2)10-18(21-30-8-6-24-7-9-31-21)26-20(28)17(12-29-3)25-19(27)15-11-14(22)4-5-16(15)23/h4-5,11,13,17-18,24H,6-10,12H2,1-3H3,(H,25,27)(H,26,28)/t17-,18-/m0/s1

Standard InChI Key:  SOGYIICGUUSWIE-ROUUACIJSA-N

Molfile:  

     RDKit          2D

 31 32  0  0  0  0  0  0  0  0999 V2000
    4.1351  -10.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8517  -10.7507    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1320   -9.5177    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5653  -10.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820  -10.7453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9956  -10.3321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2851  -11.5704    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7123  -10.7399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4258  -10.3268    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    7.7153  -11.5650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4320  -11.9770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4351  -12.8021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1415  -11.5597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5622   -9.5124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4223  -10.7553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7154  -10.3454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0031  -10.7571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0055  -11.5821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7261  -11.9935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4314  -11.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7150   -9.5203    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.7319  -12.8186    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.2758   -9.0951    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2727   -8.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3088   -9.5101    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8102   -8.8526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6280   -8.7424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2853   -9.2398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3955  -10.0575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8940  -10.7148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0764  -10.8250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  6
 10 11  1  0
 11 12  1  0
 11 13  1  0
  4 14  1  1
  1 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 16 21  1  0
 19 22  1  0
 14 23  1  0
 23 24  1  0
  9 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31  9  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4248209

    ---

Associated Targets(Human)

PSMB2 Tclin Proteasome Macropain subunit (1025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB1 Tclin Proteasome component C5 (935 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB5 Tclin Proteasome Macropain subunit MB1 (2451 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-266 (527 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ARH-77 (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 474.19Molecular Weight (Monoisotopic): 473.1656AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Lei M, Feng H, Bai E, Zhou H, Wang J, Shi J, Wang X, Hu S, Liu Z, Zhu Y..  (2018)  Design, synthesis, in vitro and in vivo evaluation, and structure-activity relationship (SAR) discussion of novel dipeptidyl boronic acid proteasome inhibitors as orally available anti-cancer agents for the treatment of multiple myeloma and mechanism studies.,  26  (14): [PMID:29934218] [10.1016/j.bmc.2018.06.020]

Source